Literature DB >> 33456528

Association between IL-33 and other inflammatory factors in patients with rheumatoid arthritis and in fibroblast-like synoviocytes in vitro.

Jing Wu1, Qiang Li1, Jiaxin Deng1, Jin-Jun Zhao2, Qing-Hong Yu1.   

Abstract

IL-33 is a member of the IL-1 family of cytokines whose role remains controversial in rheumatoid arthritis (RA). The present study was performed to evaluate the correlation of IL-33 with other cytokines and chemokines in serum and the synovia, and to explore the nature of the association. The concentration of IL-33 in samples from 96 patients with RA was analyzed. The response of fibroblast-like synoviocytes (FLSs) to treatment with different concentrations of IL-33 was assessed in vitro. IL-33 was indicated to exhibit an association with multiple cytokines and chemokines in synovial fluid with an inverted-U-shaped trend, including IL-6, IL-1β, IL-8, MIG and IP-10, but not in the serum. Furthermore, in vitro experiments confirmed that IL-33 also exerted a U-type dose-dependent regulatory effect on FLS function. In addition, the data-points do not exactly follow the U-shaped curve fit in most cases, therefore, the applicability of this mathematical model in clinical practice is limited.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  IL-33; chemokines; cytokines; fibroblast-like synoviocytes; rheumatoid arthritis

Year:  2020        PMID: 33456528      PMCID: PMC7792477          DOI: 10.3892/etm.2020.9592

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  26 in total

Review 1.  IL-33: a promising therapeutic target for rheumatoid arthritis?

Authors:  Feng-Lai Yuan; Xia Li; Wei-Guo Lu; Cheng-Wan Li; Rui-Sheng Xu; Jian Dong
Journal:  Expert Opin Ther Targets       Date:  2011-02-26       Impact factor: 6.902

2.  Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.

Authors:  Dominique Talabot-Ayer; Thomas McKee; Patrizia Gindre; Sylvette Bas; Dominique L Baeten; Cem Gabay; Gaby Palmer
Journal:  Joint Bone Spine       Date:  2011-03-26       Impact factor: 4.929

Review 3.  Embracing novel cytokines in RA - complexity grows as does opportunity!

Authors:  Axel J Hueber; Darren L Asquith; Iain B McInnes; Ashley M Miller
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-08       Impact factor: 4.098

4.  Ability of Interleukin-33- and Immune Complex-Triggered Activation of Human Mast Cells to Down-Regulate Monocyte-Mediated Immune Responses.

Authors:  Felice Rivellese; Jolien Suurmond; Kim Habets; Annemarie L Dorjée; Nandhini Ramamoorthi; Michael J Townsend; Amato de Paulis; Gianni Marone; Tom W J Huizinga; Costantino Pitzalis; René E M Toes
Journal:  Arthritis Rheumatol       Date:  2015-09       Impact factor: 10.995

5.  IL-33 exacerbates autoantibody-induced arthritis.

Authors:  Damo Xu; Hui-Rong Jiang; Yubin Li; Peter N Pushparaj; Mariola Kurowska-Stolarska; Bernard P Leung; Rong Mu; Hwee Kee Tay; Andrew N J McKenzie; Iain B McInnes; Alirio J Melendez; Foo Y Liew
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

6.  Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis.

Authors:  Eun-Ju Lee; Min Wook So; Seokchan Hong; Yong-Gil Kim; Bin Yoo; Chang-Keun Lee
Journal:  Cytokine       Date:  2015-10-29       Impact factor: 3.861

7.  Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis.

Authors:  Yasushi Matsuyama; Hitoaki Okazaki; Hiroyuki Tamemoto; Hirotaka Kimura; Yasuyuki Kamata; Katsuya Nagatani; Takao Nagashima; Morisada Hayakawa; Masahiro Iwamoto; Taku Yoshio; Shin-ichi Tominaga; Seiji Minota
Journal:  J Rheumatol       Date:  2009-11-16       Impact factor: 4.666

8.  Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.

Authors:  Gaby Palmer; Dominique Talabot-Ayer; Céline Lamacchia; Dean Toy; Christian A Seemayer; Sébastien Viatte; Axel Finckh; Dirk E Smith; Cem Gabay
Journal:  Arthritis Rheum       Date:  2009-03

9.  IL-33 exacerbates antigen-induced arthritis by activating mast cells.

Authors:  Damo Xu; Hui-Rong Jiang; Peter Kewin; Yubin Li; Rong Mu; Alasdair R Fraser; Nick Pitman; Mariola Kurowska-Stolarska; Andrew N J McKenzie; Iain B McInnes; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

10.  High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis.

Authors:  Peter Ruschpler; Peter Lorenz; Wolfram Eichler; Dirk Koczan; Claudia Hänel; Roger Scholz; Christian Melzer; Hans-Jürgen Thiesen; Peter Stiehl
Journal:  Arthritis Res Ther       Date:  2003-06-26       Impact factor: 5.156

View more
  1 in total

1.  Association Between Sleep Traits and Rheumatoid Arthritis: A Mendelian Randomization Study.

Authors:  Rui-Chen Gao; Ni Sang; Cheng-Zhen Jia; Meng-Yao Zhang; Bo-Han Li; Meng Wei; Guo-Cui Wu
Journal:  Front Public Health       Date:  2022-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.